Drugs / UCL70805F
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07500805 | May 2026 → May 2028 expected | clear cell renal carcinoma | UTC Therapeutics Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UCL70805F | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07500805 ↗ |
| Route | Intravenous | “single intravenous infusion of UCL70805F” NCT07500805 ↗ |